SCHEMBL7974549

SCHEMBL7974549

COc1ccc(O)c(C=CCCCCO)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.51
GABRA3 P34903 1/20 0.49
GABRA2 P47869 1/20 0.49
GABRB2 P47870 1/20 0.49
BACE1 P56817 2/20 0.47
MAPT P10636 2/20 0.45
APP P05067 1/20 0.45
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 2/20 0.43
CA2 P00918 3/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.41
TRIM24 O15164 1/20 0.41
TYR P14679 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
ABL1 P00519 1/20 0.40
ABCB1 P08183 1/20 0.40
BCR P11274 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974543 1.00 ERN1 (0.51) ERN1GABRA3GABRA2GABRB2BACE1
SCHEMBL8446850 0.83 GABRA3 (0.51) ERN1GABRA3GABRA2GABRB2BACE1
SCHEMBL7991886 0.80 ERN1 (0.59) ERN1GABRA3GABRA2GABRB2BACE1
SCHEMBL7991883 0.80 ERN1 (0.59) ERN1GABRA3GABRA2GABRB2BACE1
SCHEMBL13528990 0.78 CYP1A2 (0.62) MAPTKDM4EALDH1A1KMT2ACYP1A2
SCHEMBL9148376 0.76 LTB4R (0.49) KDM4EALDH1A1NPC1RAB9AABL1
SCHEMBL8416685 0.76 LTB4R (0.49) KDM4EALDH1A1NPC1RAB9AABL1
SCHEMBL9473131 0.74 ALDH1A1 (0.45) BACE1MAPTAPPKDM4EALDH1A1
SCHEMBL7988046 0.74 ERN1 (0.65) ERN1GABRA3GABRA2GABRB2BACE1
SCHEMBL7988050 0.74 ERN1 (0.65) ERN1GABRA3GABRA2GABRB2BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010024798-A1 Biomimetic combinatorial synthesis SHAIR MATTHEW D (US) 2001-09-27 US disclosed
WO-1999064379-A2 BIOMIMETIC COMBINATORIAL SYNTHESIS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1999-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010024798-A1 Biomimetic combinatorial synthesis COASY, BBOX1, CYP4B1 ERN1 1036/4885GABRA3 1680/4885GABRA2 1651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.